China’s self-developed novel tuberculosis mRNA vaccine started a clinical trial at Beijing Chest Hospital on Monday, according to the local...
Vous n'êtes pas connecté
China’s self-developed novel tuberculosis mRNA vaccine started a clinical trial at Beijing Chest Hospital on Monday, according to the local newspaper Beijing Evening News. Previous animal experiments have shown that the new vaccine’s protective efficacy is more than 20 times higher than that of both Bacillus Calmette-Guerin (BCG) and foreign tuberculosis vaccines. The tuberculosis vaccine, […]
China’s self-developed novel tuberculosis mRNA vaccine started a clinical trial at Beijing Chest Hospital on Monday, according to the local...
As we mark World TB Day on 24 March, we stand on the threshold of creating only the second tuberculosis vaccine ever, and the first in more than a...
As we mark World TB Day on 24 March, we stand on the threshold of creating only the second tuberculosis vaccine ever, and the first in more than a...
A Phase 3 trial for the tuberculosis vaccine known as M72/AS01E is running a year ahead of schedule and has already recruited 90% of the 20,000 people...
A Phase 3 trial for the tuberculosis vaccine known as M72/AS01E is running a year ahead of schedule and has already recruited 90% of the 20,000 people...
Joe Rogan Guest & Dr. Suzanne HumphriesHHS cuts 10000 employees - Calling the Shots: Tracking RFK Jr. on VaccinesSoTW - Translated from Norwegian...
A Phase 1 clinical trial for a Lassa virus (LASV) vaccine has been developed by a team of researchers from Thomas Jefferson University, in...
Scientists in the US who do research on mRNA technology worry their funding may be cut under President Trump. mRNA technology is the basis for COVID-...